Our Impact

Since we began in 2001, m2m has…

Created over 11,000 jobs for women living with HIV.

Reached more than 11M women and children under two in sub-Saharan Africa.

We undertake in-depth programme reviews every year.

We also release regular quarterly reports with our latest reach and impact.

DOWNLOAD 2019 ANNUAL PROGRAMME REVIEW

DOWNLOAD LATEST QUARTERLY REPORT

In 2019, m2m…

Grew in scale

932,431

new clients were reached by our programme, a 4% increase from the year before.

1,781

women living with HIV were employed directly by m2m as frontline health workers called “Mentor Mothers.”

498

locations in which Mentor Mothers provided direct services, including health facilities and in the surrounding communities—a 57% increase over 2018.

Took a step closer to an HIV-free generation

1.9%

is the mother-to-child HIV transmission rate among enrolled m2m clients—well below the 5% UN benchmark. This makes 2019 the sixth straight year we have achieved virtual elimination.

97%

of infants born to m2m clients living with HIV received antiretroviral medication, significantly up from 90% in 2018.

84%

of children born to m2m clients living with HIV received a final HIV test between 18-24 months, a significant increase from 75% in 2018. This highlights how m2m is keeping our clients in care through the breastfeeding period, when 47% of infections occur. [1]

1.^ UNICEF 2018: https://data.unicef.org/resources/women-at-the-heart-of-the-hiv-response-for-children/

Improved the health of women, children, and adolescents

Women

99%

of women we served who are living with HIV accessed treatment, substantially higher than an 85% benchmark in Eastern and Southern Africa. [2]

0.08%

of pregnant or breastfeeding women who were HIV-negative when enrolled into our programme contracted HIV in 2019—45 times lower than a 2020 rate across sub-Saharan Africa of 3.6%. [3]

98%

of our clients living with HIV were adherent to their treatment more than 95% of the time—surpassing World Health Organization goals (95% of individuals with 80% adherence).

90%

of m2m clients living with HIV who started antiretroviral therapy for the first time were still on treatment after a year— compared to 72% in Eastern and Southern Africa. [4]

2.^ UNAIDS 2019: Eastern and Southern Africa

3.^https://journals.lww.com/aidsonline/Abstract/2020/04010/Incident_HIV_among_pregnant_and_breast_feeding.12.aspx

4.^ UNAIDS 2019: Eastern and Southern Africa

Children

91%

of children we served who are living with HIV (aged 0-9) accessed treatment—compared to a benchmark of 76%.[5]

94%

of our early childhood development clients (aged 0-3) achieved all their developmental milestones at one year of age.

5.^ UNAIDS 2019 (Note: Among the benchmarks for children in the countries included in this analysis—Kenya, Lesotho, Malawi, Zambia—Zambia had the highest rate of 76%.)

Adolescents

182,431

adolescents (aged 10-19) were enrolled in our programme in 2019 —a 27% rise over the previous year.

96%

of our adolescent clients (aged 10-19) living with HIV were initiated on treatment—compared to a benchmark of 56% in UNAIDS 35 Fast-Track countries.[6]